Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,807,747
-
Share change
-
+116,373
-
Total reported value
-
$2,260,740,338
-
Put/Call ratio
-
98%
-
Price per share
-
$108.65
-
Number of holders
-
157
-
Value change
-
-$18,776,198
-
Number of buys
-
80
-
Number of sells
-
75
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2016
As of 31 Dec 2016,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,807,747 shares.
The largest 10 holders included
FMR LLC, AMERIPRISE FINANCIAL INC, Capital World Investors, Carmignac Gestion, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, JPMORGAN CHASE & CO, STATE STREET CORP, BlackRock Fund Advisors, and HIGHFIELDS CAPITAL MANAGEMENT LP.
This page lists
157
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.